Cancer Cognitive Computing Market to Reach Value of USD 4 Bn, Predicts RNCOS E-Services in Its New Research Study Available at MarketPublishers.com
22 Nov 2016 • by Natalie Aster
LONDON – The introduction of cognitive computing for cancer (allowing a previously unattainable level of personalized treatment options with simplicity and efficiency) has recently revolutionised the global healthcare industry.
The worldwide market for cancer cognitive computing market is predicted to see remarkable growth through 2022, spurred by impressive advancements in computing platforms, rising cancer incidence, expanding adoption of cognitive computing software in hospitals and also rising big and complex genomic databases. The value of the world’s cancer cognitive computing market is anticipated to touch USD 4 billion.
North America is the current leader in the world’s market for cancer cognitive computing, whilst APAC is anticipated to register the highest growth rates in the next five years.
The cutting-edge research report by RNCOS E-Services, “Global Cancer Cognitive Computing Market Outlook 2022”, offers unbiased insights into the worldwide market for cancer cognitive computing.
The research study describes the current scenario and presents data on historical background, points out key emerging opportunities in the area, examines the main factors influencing the market growth, discusses top development trends and also uncovers an overview of competitive environment and profiles dominant players.
The report helps to understand and evaluate the potential of each region for cancer cognitive computing, uncovers data on the number of cancer specialty hospitals in each region, offers info on cancer prevalence in various geographical areas.
Additionally, this study contains future forecasts for the cancer cognitive computing market through 2022 and identifies top growth prospects and lucrative growth areas.
To find other new market research studies by RNCOS E-Services, follow to the publisher’s page at MarketPublishers.com.